You are leaving this site You are about to leave www.grantformultiplesclerosisinnovation.org/. The content of the site you are about to visit is not controlled by www.grantformultiplesclerosisinnovation.org/.

Grant for Multiple Sclerosis Innovation

The review and award process


Following receipt of the completed questionnaire, selected applicants will be invited to submit a formal protocol and detailed budget for their study. Based on this information, the Scientific Committee will make their final acceptance decisions.


The Scientific Committee for the Innovation Grant is completely independent and consists of external leaders in the field. The Committee undertakes a rigorous process of review and assessment of eligible projects, before validating its selection of grant Awardees.


The names of the applicants and their institutions are completely blind to the members of the Scientific Committee to keep the scientific merit of the proposals as the key criteria for selection. All proposals are rated from 1 to 5 (with 5 being the highest) against each of the following criteria:


  • Relevance to clinical practice
  • Innovative research
  • Scientific rationale
  • Feasibility
  • Practical utility


A final score is then calculated and the projects ranked accordingly. After each round of selection, successful applicants will be contacted individually to inform them of the status of their application and eventually request additional information. All projects that pass to the second round of review will have to submit the formal protocol, the budget and a signed document that confirms their acceptance of the Grant for Multiple Sclerosis Innovation rules and regulations for advanced applications.


1. How is the awarding of the grant formalised?


The awarding of the Innovation Grant is subject to the signature of a Grant Agreement between EMD Serono and the (main investigator's) Institution. The Agreement documents the conditions of the grant and the further collaboration between EMD Serono and the Institution together with the main investigator of the respective project.


2. Do Awardees have to get involved in publicity surrounding the GMSI?


EMD Serono retains the exclusive right to make any press release or any kind of public communication about the Grant for Multiple Sclerosis Innovation, the grant(s) and the Awardee(s).


EMD Serono would encourage the Awardee(s) to present any data at ECTRIMS on project completion.


3. What happens to applications that are not successful?


EMD Serono treats all submissions confidentially and information relating to submissions which are not selected for a grant is destroyed.


The Scientific Committee are not able to provide neither feedback nor explanation on the reason why projects have been unsuccessful.